1 Nancy U. Lin, MD, Dana-Farber Cancer Institute, Boston, MA; Mark Pegram, MD, Stanford Comprehensive Cancer Institute, Palo Alto, CA; Solmaz Sahebjam, MD, Moffitt Cancer Center, University of South Florida, Tampa, FL; Nuhad Ibrahim, MD, MD Anderson Cancer Center, Houston, TX; Anita Fung, PharmD, Anna Cheng, PharmD, Alan Nicholas, PhD, and Whitney Kirschbrown, PharmD, PhD, Genentech Inc., South San Francisco, CA; and Priya Kumthekar, MD, Northwestern University, Chicago, IL.